NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BioXcel Therapeutics, Inc. ("BioXcel" or the "Company") (NASDAQ:BTAI) and certain of its officers.
Class Definition:
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired BioXcel securities between December 15, 2021 and June 28, 2023, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/btai.
Case Details:
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose ...
BTAI) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!>Full story available on Benzinga.com